Denali Therapeutics saw the highest growth of 4.32% in patent filings in May and 0.39% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.29% and grants by 0.39%. GlobalData’s DataBook provides a comprehensive analysis of Denali Therapeutics‘s patent filings and grants. Buy the databook here.
Denali Therapeutics has been focused on protecting inventions in World Intellectual Property Organization(WIPO) with ten publications in Q2 2024
The World Intellectual Property Organization(WIPO) Patent Office dominates the patent filings with nearly 43% of filings. The World Intellectual Property Organization(WIPO), United States(US), European Patent Office(EPO), and Israel(IL) patent Office are among the top ten patent offices where Denali Therapeutics is filings its patents. Among the top granted patent authorities, Denali Therapeutics has 67% of its grants in United States(US) and 33% in Australia(AU).
Roche could be the strongest competitor for Denali Therapeutics
Patents related to rare diseases and addiction lead Denali Therapeutics's portfolio
Denali Therapeutics has the highest number of patents in rare diseases followed by, addiction and Covid-19. For rare diseases, nearly 75% of patents were filed and 75% of patents were granted in Q2 2024.
Parkinson's disease related patents lead Denali Therapeutics portfolio followed by lewy body dementia, and dementia
Denali Therapeutics has highest number of patents in parkinson's disease followed by lewy body dementia, dementia, amyotrophic lateral sclerosis, and multiple sclerosis. For parkinson's disease, nearly 4% of patents were filed and 2% of patents were granted in Q2 2024.
For comprehensive analysis of Denali Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.